- UHRA Home
- Browsing by Author
Browsing by Author "Poltawski, L."
Now showing items 1-7 of 7
-
Cutaneous side effects of infused apomorphine: The patient and care experience
Poltawski, L.; Edwards, H.; Todd, A.; Watson, T.; Lees, A.; James, C. (2008-12)Subcutaneously infused apomorphine, used in the treatment of Parkinson's disease, is associated with the development of hard nodules at the infusion site. They may interfere with drug absorption and make it difficult to ... -
Physiotherapists’ perceptions of problematic musculoskeletal soft tissue disorders
Poltawski, L.; Watson, T.; Byrne, G. (2008)Aims: Many common musculoskeletal disorders are resistant to existing management strategies,causing long-term pain and disability. While arthritic and spinal problems have been prioritized for research, several soft tissue ... -
Relative transmissivity of ultrasound coupling agents commonly used by therapists in the UK
Poltawski, L.; Watson, T. (2007)Coupling agents are required when using therapeutic ultrasound (US) to maximize acoustic contact between the transducer and the insonated tissue. US beam power is attenuated to varying extents by different couplants and ... -
Sonographic characterisation of tissue changes associated with infused apomorphine hydrochloride – a case series
Edwards, H.; Poltawski, L.; Todd, A. (2008-08)Apomorphine hydrochloride is used to treat refractory motor fluctuations in advanced Parkinson’s disease. Delivery by infusion is associated with the formation of hard subcutaneous nodules, which may be painful, limit ... -
Transmission of therapeutic ultrasound by wound dressings
Poltawski, L.; Watson, T. (2007)Ultrasound has been used for the treatment of a variety of cutaneous wounds, particularly venous ulcers. Many of the published studies involved application of ultrasound to the surrounding tissue rather than directly over ... -
Transmission of therapeutic ultrasound by wound dressings (vol 19, pg 1, 2007)
Poltawski, L.; Watson, T. (2007-02) -
Ultrasound treatment of cutaneous side-effects of infused apomorphine: a randomized controlled pilot study
Poltawski, L.; Edwards, H.; Todd, A.; Watson, T.; Lees, A.; James, C. (Movement Disorders Society, 2009-01-15)Apomorphine hydrochloride is a dopamine agonist used in the treatment of advanced Parkinson's disease. Its administration by subcutaneous infusions is associated with the development of nodules that may interfere with ...